BEAUFORT, S.C.–(BUSINESS WIRE)–Recent research published by THE SAGE GROUP examines the challenges of infrapopliteal Peripheral Artery Disease (PAD) and incidence of restenosis. “It is difficult to reach strong conclusions regarding device superiority for endovascular treatment of infrapopliteal disease,” stated Mary […]
Tag: The Sage Group
THE SAGE GROUP Comments on National Peripheral Artery Disease (PAD) Awareness Month
BEAUFORT, S.C.–(BUSINESS WIRE)–According to THE SAGE GROUP, 21 million Americans suffer from PAD representing an economic burden of $283-$539 billion. “Twenty years ago we wrote that PAD was underestimated, underdiagnosed and undertreated,” stated Mary L. Yost, President. “Unfortunately, this is […]
According to THE SAGE GROUP, Gender is a Significant Factor in African American (AA) Peripheral Artery Disease (PAD) Disparities
BEAUFORT, S.C.–(BUSINESS WIRE)–Research published by THE SAGE GROUP examines PAD disparities in African Americans and the contributing factors, as well as quantifies PAD prevalence in AA. “While it is well known that African Americans have a higher prevalence of PAD, […]
According to THE SAGE GROUP, Thrombus is Highly Prevalent in Both Symptomatic and Asymptomatic Peripheral Artery Disease (PAD) Patients
BEAUFORT, S.C.–(BUSINESS WIRE)–A new analysis published by THE SAGE GROUP concludes that occlusive thrombus is present in 3.6 million PAD patients. “Occlusive thrombus in the leg arteries has serious consequences including ischemic symptoms, and in severe cases amputation. Furthermore, its […]
THE SAGE GROUP Announces Publication of U.S. Acute Limb Ischemia (ALI) Incidence and Market Estimates
BEAUFORT, S.C.–(BUSINESS WIRE)–A new analysis published by THE SAGE GROUP concludes that ALI represents a substantial market opportunity for pharmaceutical and interventional therapies. “Although the number of patients currently treated for an acute occlusion in the lower limbs is relatively […]